Search

Displaying results 9641 - 9650 of 10000 in total
  1. Drug

    Oxiniacic acid

    go.drugbank.com/drugs/DB21422
    Experimental

    Oxiniacic acid is a small molecule drug. Oxiniacic acid has a monoisotopic molecular weight of 139.03 Da.

  2. Drug

    Persilic acid

    go.drugbank.com/drugs/DB19792
    Experimental

    Persilic acid is a small molecule drug. Persilic acid has a monoisotopic molecular weight of 269.95 Da.

  3. Drug

    Cinametic acid

    go.drugbank.com/drugs/DB19826
    Experimental

    Cinametic acid is a small molecule drug. Cinametic acid has a monoisotopic molecular weight of 238.08 Da.

  4. Drug

    Salclobuzic acid

    go.drugbank.com/drugs/DB19931
    Experimental

    Salclobuzic acid is a small molecule drug. Salclobuzic acid has a monoisotopic molecular weight of 257.05 Da.

  5. Drug

    Clamidoxic acid

    go.drugbank.com/drugs/DB19938
    Experimental

    Clamidoxic acid is a small molecule drug. Clamidoxic acid has a monoisotopic molecular weight of 339.01 Da.

  6. Drug

    Sulfaloxic acid

    go.drugbank.com/drugs/DB19971
    Experimental

    Sulfaloxic acid is a small molecule drug. Sulfaloxic acid has a monoisotopic molecular weight of 393.06 Da.

  7. Drug

    GS030-DP

    go.drugbank.com/drugs/DB17847
    Investigational

    GS030-DP is an optogenetic gene therapy being investigated for the treatment of retinitis pigmentosa. … It is a component of GS030, an investigational optogenetic treatment, in combination with a medical device GS030-MD.[A259816, L46701]

  8. Drug

    DCLL-9718S

    go.drugbank.com/drugs/DB17392
    Investigational

    DCLL9718S is an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1). … DCLL9718S is under investigation in clinical trial NCT03298516 (A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine

  9. Drug

    Polyvalent antigen-KLH conjugate vaccine

    go.drugbank.com/drugs/DB17565
    Investigational

    It is under investigation in clinical trial NCT01223235 (Polyvalent Vaccine-klh Conjugate + Opt-821 Given in Combination With Bevacizumab). … Polyvalent antigen-KLH conjugate vaccine is a multivalent cancer vaccine comprised of the five tumor-associated antigens (TAAs) globo H, GM2 ganglioside, Tn-MUC1, TF, and sTn conjugated with the immunoadjuvant

  10. Drug

    AC-003

    go.drugbank.com/drugs/DB22691
    Investigational

    AC-003 is a selective, oral small-molecule inhibitor of receptor-interacting protein kinase 1 (RIPK1). … [L53458] It is being investigated for the treatment of acute graft-versus-host disease (GVHD) and idiopathic pulmonary fibrosis (IPF).[L53458]